Avanos Medical (AVNS) Competitors

Avanos Medical (NYSE:AVNS) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings, profitability and community ranking.

Does the MarketBeat Community favor AVNS or TMDX?

TransMedics Group received 25 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 59.26% of users gave TransMedics Group an outperform vote while only 55.77% of users gave Avanos Medical an outperform vote.

Company	Underperform	Outperform
Avanos Medical	Outperform Votes 87 55.77%	Underperform Votes 69 44.23%
TransMedics Group	Outperform Votes 112 59.26%	Underperform Votes 77 40.74%

Do analysts rate AVNS or TMDX?

TransMedics Group has a consensus target price of $122.70, suggesting a potential upside of 75.25%. Given TransMedics Group's stronger consensus rating and higher probable upside, analysts clearly believe TransMedics Group is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
TransMedics Group	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.82

Do insiders and institutionals hold more shares of AVNS or TMDX?

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 2.9% of Avanos Medical shares are owned by company insiders. Comparatively, 7.0% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has more risk & volatility, AVNS or TMDX?

Avanos Medical has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.12, meaning that its stock price is 112% more volatile than the S&P 500.

Does the media favor AVNS or TMDX?

In the previous week, TransMedics Group had 37 more articles in the media than Avanos Medical. MarketBeat recorded 52 mentions for TransMedics Group and 15 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 0.33 beat TransMedics Group's score of 0.19 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	6 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
TransMedics Group	13 Very Positive mention(s)	4 Positive mention(s)	29 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral

Which has preferable earnings & valuation, AVNS or TMDX?

TransMedics Group has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$687.80M	0.96	-$61.80M	-$8.53	-1.68
TransMedics Group	$441.54M	5.34	-$25.03M	$1.01	69.32

Is AVNS or TMDX more profitable?

TransMedics Group has a net margin of 8.14% compared to Avanos Medical's net margin of 2.30%. TransMedics Group's return on equity of 18.74% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	2.30%	4.70%	3.46%
TransMedics Group	8.14%	18.74%	4.39%

Summary

TransMedics Group beats Avanos Medical on 17 of the 19 factors compared between the two stocks.